Sterigenics International continues growth with acquisition of leading Italian sterilization company

摘要

Sterigenics International LLC, a leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of GTCR, has announced it has acquired Gammarad, Italy's leading gamma sterilization provider. "In addition to these strategic acquisitions, Sterigenics has committed more than $32 million in growth capital to expand existing facilities across the Americas and Europe" Cammarad, established in 1969 and located in Bologna, Italy, provides gamma irradiation sterilization services for the biomedical, pharmaceutical, food packaging, and cosmetics industries. "With over 4 million cubic feet of processing capability, this is an important piece to the Sterigenics strategy to continue to expand our global footprint and market position as the leading solutions based provider in contract sterilization," said Philip Macnabb, President of Sterigenics International LLC. "With this second Gamma irradiation site in Western Europe, Sterigenics can now offer redundancy to our current customers as well as those of Cammarad.